Globus Medical
GMED
120 hedge funds and large institutions have $899M invested in Globus Medical in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 8 closing their positions.
175% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 8
72% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 32
49% more call options, than puts
Call options by funds: $318K | Put options by funds: $213K
36% more capital invested
Capital invested by funds: $661M → $899M (+$238M)
18.06% more ownership
Funds ownership: 60.73% → 78.79% (+18%)
12% more funds holding
Funds holding: 107 → 120 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$45.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$24.2M |
| 3 |
DM
Deerfield Management
New York
|
+$20.7M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$17.4M |
| 5 |
Bank of New York Mellon
New York
|
+$14.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$17.1M |
| 2 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$6.2M |
| 3 |
Neuberger Berman Group
New York
|
-$4.92M |
| 4 |
RA
Royce & Associates
New York
|
-$2.92M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.83M |
GMED Hedge Fund Activity: Q3 2013 in Review
120 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2013, worth a combined $899M — up 36% from $661M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new GMED positions and 8 closed out — a net gain of 14 holders — while 55 added to existing stakes and 32 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $45.3M. The largest seller was Goldman Sachs, cutting an estimated $17.1M.
- 120 institutional investors held Globus Medical (GMED) as of Q3 2013, up from 107 in Q2 2013.
- Funds reported $899M of Globus Medical stock for Q3 2013, up 36% quarter-over-quarter.
- 22 funds opened new Globus Medical positions in Q3 2013 and 8 closed out, a net change of +14 holders.
- The largest Globus Medical buyer in Q3 2013 was Wellington Management Group, an estimated $45.3M added.
- The largest Globus Medical seller in Q3 2013 was Goldman Sachs, an estimated $17.1M sold.
Based on aggregated 13F filings for Q3 2013.